Analyst Price Target is GBX 0
This price target is based on 0 analysts offering 12 month price targets for LiDCO Group Plc (LID.L) in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a NaN upside from the last price of GBX 0.
Current Consensus is
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in LiDCO Group Plc (LID.L). This N/A consensus rating has held steady for over two years.
LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company provides LiDCOunity, a hemodynamic monitor to support clinical decision making; LiDCOrapid, a monitor that analyses the blood pressure waveform to provide information in surgical and critically ill patients to help with fluid and drug management; LiDCOview that offers clinical researchers and users with beat-to-beat hemodynamic data; LiDCOplus, a hemodynamic monitor, which provides assessment of the hemodynamic status of critical care and surgery patients; and accessories, including blood pressure modules. It also offers various closed and open pressure monitoring sets for use in the ICU, operating department, and Cath labs; and Stimpod NMS 450X, a quantitative neuromuscular blocking agent monitor. LiDCO Group Plc was founded in 1991 and is headquartered in London, the United Kingdom.
Read More
